- Record: found
- Abstract: found
- Article: found
Is Open Access
research-article
Read this article at
ScienceOpenPublisherPMC
- Download PDF
- XML
- Review article
- Invite someone to review
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Proposed framework for classifying coexisting mitral regurgitation and severe LV systolic dysfunction. This framework is based on ancillary analyses of randomized clinical trials and prospective validation is pending. ERO: effective regurgitant orifice. EDV: end-diastolic volume. TMVr: transcatheter mitral valve repair. Graphical Abstract
Related collections
Most cited references74
- Record: found
- Abstract: found
- Article: not found
Burden of Tricuspid Regurgitation inPatients Diagnosed in the CommunitySetting
Yan Topilsky, Simon Maltais, Jose R. Medina Inojosa … (2018)
This study sought to analyze patients with tricuspid regurgitation (TR) diagnosed in the community setting (Olmsted County) by Doppler echocardiography to define the prevalence, characteristics, and implications of clinically significant (greater or equal to moderate) TR.
0 comments Cited 212 times – based on 0 reviews Review now
Bookmark
- Record: found
- Abstract: found
- Article: not found
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
Raj R Makkar, Vinod H Thourani, Michael J Mack … (2020)
There are scant data on long-term clinical outcomes and bioprosthetic-valve function after transcatheter aortic-valve replacement (TAVR) as compared with surgical aortic-valve replacement in patients with severe aortic stenosis and intermediate surgical risk.
0 comments Cited 200 times – based on 0 reviews Review now
Bookmark
- Record: found
- Abstract: found
- Article: not found
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study
Gilbert Habib, Paola Anna Erba, Bernard Iung … (2019)
The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE). Prospective cohort of 3116 adult patients (2470 from Europe, 646 from non-ESC countries), admitted to 156 hospitals in 40 countries between January 2016 and March 2018 with a diagnosis of IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, and imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)] data were collected. Infective endocarditis was native (NVE) in 1764 (56.6%) patients, prosthetic (PVIE) in 939 (30.1%), and device-related (CDRIE) in 308 (9.9%). Infective endocarditis was community-acquired in 2046 (65.66%) patients. Microorganisms involved were staphylococci in 1085 (44.1%) patients, oral streptococci in 304 (12.3%), enterococci in 390 (15.8%), and Streptococcus gallolyticus in 162 (6.6%). 18F-fluorodeoxyglucose positron emission tomography/computed tomography was performed in 518 (16.6%) patients and presented with cardiac uptake (major criterion) in 222 (42.9%) patients, with a better sensitivity in PVIE (66.8%) than in NVE (28.0%) and CDRIE (16.3%). Embolic events occurred in 20.6% of patients, and were significantly associated with tricuspid or pulmonary IE, presence of a vegetation and Staphylococcus aureus IE. According to ESC guidelines, cardiac surgery was indicated in 2160 (69.3%) patients, but finally performed in only 1596 (73.9%) of them. In-hospital death occurred in 532 (17.1%) patients and was more frequent in PVIE. Independent predictors of mortality were Charlson index, creatinine > 2 mg/dL, congestive heart failure, vegetation length > 10 mm, cerebral complications, abscess, and failure to undertake surgery when indicated. Infective endocarditis is still a life-threatening disease with frequent lethal outcome despite profound changes in its clinical, microbiological, imaging, and therapeutic profiles.
0 comments Cited 189 times – based on 0 reviews Review now
Bookmark
All references
Author and article information
Journal
Journal ID (nlm-ta): Eur Heart J
Journal ID (iso-abbrev): Eur Heart J
Journal ID (publisher-id): eurheartj
Title: European Heart Journal
Publisher: Oxford University Press
ISSN (Print): 0195-668X
ISSN (Electronic): 1522-9645
Publication date Collection: 07 February 2021
Publication date (Electronic): 03 January 2021
Publication date PMC-release: 03 January 2021
Volume: 42
Issue: 6 , Focus Issue on Heart Failure and Cardiomyopathies
Pages: 647-656
Affiliations
Author notes
Corresponding author. Tel: +34 91 5868279, Fax: +34 91 5866727, Email: javier.bermejo@ 123456salud.madrid.org
Author information
Javier Bermejo http://orcid.org/0000-0002-5241-2758
Andrea Postigo http://orcid.org/0000-0003-0640-3604
Helmut Baumgartner http://orcid.org/0000-0002-9542-8821
Article
Publisher ID: ehaa1060
DOI: 10.1093/eurheartj/ehaa1060
PMC ID: 7878012
PubMed ID: 33388778
SO-VID: 3e44a322-b5b3-452b-a7fe-895cc6b8c4f0
Copyright © © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
License:
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
History
Date received : 30 September 2020
Date revision received : 11 November 2020
Date accepted : 16 December 2020
Date: 10 December 2020
Page count
Pages: 10
Categories
Subject: Special Articles
Subject: Editor's Choice
Subject: AcademicSubjects/MED00200
ScienceOpen disciplines: Cardiovascular Medicine
Keywords: valvular heart disease
Data availability:
ScienceOpen disciplines: Cardiovascular Medicine
Keywords: valvular heart disease
Comments
Comment on this article
Sign in to comment